Does the sequence of taxane administration affect the outcome of patients with breast cancer in the adjuvant and neoadjuvant settings?

被引：0
|
作者：
Alkan, Ali [2 ]
Sahin, Ugur [2 ]
Altundag, Kadri [1 ]
机构：
[1] Hacettepe Univ, Dept Med Oncol, Inst Oncol, TR-06100 Ankara, Turkey
[2] Hacettepe Univ, Sch Med, Dept Internal Med, TR-06100 Ankara, Turkey
来源：
MEDICAL ONCOLOGY | 2010年 / 27卷 / 04期
关键词：
Paclitaxel; Docetaxel; Gemcitabin; Taxane; Anthracycline;
D O I：
10.1007/s12032-009-9322-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1430 / 1430
页数：1
相关论文
共 50 条
  • [1] Does the sequence of taxane administration affect the outcome of patients with breast cancer in the adjuvant and neoadjuvant settings?
    Ali Alkan
    Ugur Sahin
    Kadri Altundag
    Medical Oncology, 2010, 27 : 1430 - 1430
  • [2] Does combination of neoadjuvant and adjuvant chemotherapy improve outcome in operable breast cancer patients?
    Knauer, M.
    Haid, A.
    de Vries, A.
    Schneider, Y.
    Lang, A.
    Winder, T.
    Alton, R.
    Wenzl, E.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S228 - S228
  • [3] Does the Timing of Surgery after Neoadjuvant Therapy in Breast Cancer Patients Affect the Outcome?
    Suleman, Kausar
    Almalik, Osama
    Haque, Emaan
    Mushtaq, Ali
    Badran, Ahmed
    Alsayed, Adher
    Ajarim, Dahish
    Al-Tweigeri, Taher
    Jastaniyah, Noha
    Elhassan, Tusneem
    Alkhayal, Wafa
    ONCOLOGY, 2020, 98 (03) : 168 - 173
  • [4] Toxicity in elderly breast cancer patients treated by a taxane based chemotherapy as adjuvant or neoadjuvant therapy for primary breast cancer
    Loibl, S.
    von Minckwitz, G.
    Elling, D.
    Janni, W.
    Kaufmann, M.
    Vescia, S.
    Eggemann, H.
    Harbeck, N.
    Nekljudova, V.
    Kuemmel, S.
    ANNALS OF ONCOLOGY, 2006, 17 : 158 - 158
  • [5] Late cardiotoxicity in patients with breast cancer after taxane/anthracycline-based neoadjuvant and adjuvant chemotherapy
    Koroleva, I.
    Kopp, M. V.
    Kasulin, A. N.
    Kucheryavyy, J. A.
    Byakhov, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] Does delay of adjuvant chemotherapy affect the clinical outcome in patients with colon cancer?
    Bayraktar, U. D.
    Bayraktar, S.
    Herna, S.
    Ku, N.
    Jones, C.
    Merchan, J.
    Sands, L. R.
    Marchetti, F.
    Montero, A.
    Rocha-Lima, C. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] Does neoadjuvant chemotherapy regimen affect sarcopenia status in patients with breast cancer?
    Jang, Min Kyeong
    Park, Seho
    Park, Chang
    Doorenbos, Ardith Z.
    Go, Jieon
    Kim, Sue
    BREAST, 2022, 66 : 1 - 7
  • [8] Does treatment sequence affect outcomes in patients with metaplastic breast cancer?
    Ladipo, Oluwatomi L.
    Ren, Yi
    Caddell, Keenan B.
    Sampathkumar, Anuyuga
    Almond, Chandra A.
    Fayanju, Oluwadamilola M.
    AMERICAN JOURNAL OF SURGERY, 2021, 221 (04): : 701 - 705
  • [9] Late pancreatie toxielty in patients with breast cancer after taxane-anthracycline-based neoadjuvant and adjuvant chemotherapy
    Kopp, M. V.
    Koroleva, I.
    Kasulin, A. N.
    Kucheryavyy, J. A.
    Byakhov, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Does age affect outcome with breast cancer?
    Jackson, Emily B.
    Gondara, Lovedeep
    Speers, Caroline
    Diocee, Rekha
    Nichol, Alan M.
    Lohrisch, Caroline
    Gelmon, Karen A.
    BREAST, 2023, 70 : 25 - 31
12345